Preclinical toxicological assessment of a novel monoclonal antibody targeting human platelet-derived growth factor CC (PDGF-CC) in PDGF-CC^hum mice

• Manuel Zeitelhofer ,

  Roles Investigation, Writing – original draft

  * E-mail: ulf.pe.eriksson@ki.se (UE); manuel.zeitelhofer@ki.se (MZ)

  Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Hong Li,

  Roles Investigation, Writing – original draft

  Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Milena Z. Adzemovic,

  Roles Investigation

  Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Ingrid Nilsson,

  Roles Investigation

  Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Lars Muhl,

  Roles Investigation

  Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Andrew M. Scott,

  Roles Supervision, Writing – review & editing

  Affiliation Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Melbourne, Australia

  ⨯
• Ulf Eriksson

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: ulf.pe.eriksson@ki.se (UE); manuel.zeitelhofer@ki.se (MZ)

  Affiliation Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden

  http://orcid.org/0000-0002-4439-3980

  ⨯